← Leaderboards
Alyssa Tilhou
Boston Medical Center
$563,555
Attributed
$563,555
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $189.2K · FY2023–25$200K$150K$100K$50K$0
'23
'24
'25
Funding mix
By agency
NIH$563,555 · 1
By mechanism
K08$563,555 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Medical Center
Same institution · by research overlap
- Jane M Liebschutz$5,811,997
- Rebecca A Silliman$20,082,514
- Judith Tsui$9,934,962
- Alexander Yale Walley$5,296,723
- Sarah M Bagley$2,890,622
Others in their field
Other Rising Stars on “Buprenorphine”
- Ian Gurrell · Astrazeneca Pharmaceuticals, Lp$5,256,914
- Mark Sorenson · Nirsum Laboratories, Inc.$4,866,388
- Jennifer McCormack · The Emmes Company, Llc$4,121,008
- Thomas Blue · Friends Research Institute, Inc.$3,229,153
- Kathryn Hawk · Yale University$3,201,138
- Daniel Levy · Phoenix Pharmalabs, Inc.$2,894,503
Research focus
BuprenorphineBuprenorphine TreatmentCareerCaringCessation Of LifeClinical TrialsComplexCostCost-Effectiveness RatioCravingDatabasesData ScienceDisparityDosageDoseEnsureEnvironmentEpidemicEthnic OriginEvidence Based TreatmentFentanylGuidelinesHealth InsuranceAward
Grant awards (3)
Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder$186,527
K08 · FY2025 · DA · contact PI
Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder$187,823
K08 · FY2024 · DA · contact PI
Impact of initial buprenorphine prescribing strategies on retention in care for patients with opioid use disorder$189,205
K08 · FY2023 · DA · contact PI